Simon Property Group SPG
today responded to the rejection by The Macerich Company MAC of
Simon's proposal to acquire the outstanding shares of Macerich for $91.00 per
share in cash and Simon shares, and Macerich's decision to classify its Board
of Directors without a shareholder vote and adopt a poison pill.
Simon
David Simon, Simon's Chairman and Chief Executive Officer, said, "The Macerich
Board has sent shareholders a clear message that it will do everything in its
power to block a value-creating transaction and prevent them from having a
voice in matters critical to the value of their investment. It is truly
disappointing Macerich would not even meet to discuss our proposal and
remarkable that its view on value could have changed so drastically just four
months after issuing 10.9% of its shares at the $71.00 level.
"Macerich's rejection is based on a rosy view of its future prospects.
Shareholders should closely examine Macerich's history of delivering on its
forecasts, which pales in comparison to Simon's long track record of
delivering industry-leading results that have outpaced Macerich in virtually
every operating and financial category. Based on Simon's long history of
outperforming Macerich, we are confident Macerich shareholders will realize
more value through a combination with Simon than they could on a standalone
basis.
"Macerich's decision to stagger its board without shareholder approval would
be poor corporate governance at any time, but it is particularly egregious
given that we recently notified Macerich that, should the need arise, we would
nominate a number of candidates that would constitute only a minority of their
Board. Macerich clearly does not believe its shareholders can be trusted to
decide the composition of its board when the value of their investment hangs
in the balance.
"The strategic logic of our proposal has been widely recognized, the value is
compelling, and it is not conditioned on financing or dispositions. In
addition, we are comfortable there are no legal issues with our offer, as to
General Growth or otherwise, and no other impediments – aside from the
Macerich Board – to the completing the proposed transaction. Given this
extreme, scorched-earth response, Macerich shareholders should scrutinize the
actions and motives of the Macerich Board."
BofA Merrill Lynch is acting as Simon's lead financial advisor, with Morgan
Stanley & Co. LLC also acting as a financial advisor in connection with this
transaction. Latham & Watkins LLP is acting as legal counsel to Simon.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in